Serological autoimmune markers, like the IgA anti-tissue transglutaminase (TTG) and IgA anti-endomysial (EMA) antibodies, are currently employed for routine CD screening to recognize different kinds of CD since they are susceptible and particular [23]. The gene discussed is TGM2; the disease is Cowden disease.